WO2000076490A3 - Methodes de traitement de la frequence exageree des mictions ainsi que les mictions imperieuses a l'aide de oxybutynine-(s) optiquement pure et compositions a cet effet - Google Patents
Methodes de traitement de la frequence exageree des mictions ainsi que les mictions imperieuses a l'aide de oxybutynine-(s) optiquement pure et compositions a cet effet Download PDFInfo
- Publication number
- WO2000076490A3 WO2000076490A3 PCT/US2000/040183 US0040183W WO0076490A3 WO 2000076490 A3 WO2000076490 A3 WO 2000076490A3 US 0040183 W US0040183 W US 0040183W WO 0076490 A3 WO0076490 A3 WO 0076490A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oxybutynin
- urgency
- treating urinary
- compositions
- urinary frequency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU64036/00A AU6403600A (en) | 1999-06-10 | 2000-06-09 | Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32969699A | 1999-06-10 | 1999-06-10 | |
US09/329,696 | 1999-06-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000076490A2 WO2000076490A2 (fr) | 2000-12-21 |
WO2000076490A3 true WO2000076490A3 (fr) | 2002-03-21 |
Family
ID=23286590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/040183 WO2000076490A2 (fr) | 1999-06-10 | 2000-06-09 | Methodes de traitement de la frequence exageree des mictions ainsi que les mictions imperieuses a l'aide de oxybutynine-(s) optiquement pure et compositions a cet effet |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6403600A (fr) |
WO (1) | WO2000076490A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8377956B2 (en) | 2010-03-01 | 2013-02-19 | Xenoport, Inc. | Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04273818A (ja) * | 1991-02-28 | 1992-09-30 | Kissei Pharmaceut Co Ltd | 経皮投与製剤 |
JPH05339151A (ja) * | 1992-05-30 | 1993-12-21 | Kodama Kk | 持効性塩酸オキシブチニン製剤 |
US5532278A (en) * | 1995-01-31 | 1996-07-02 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
WO1996033678A1 (fr) * | 1995-04-26 | 1996-10-31 | Theratech, Inc. | Utilisation de la triacetine comme stimulation de penetration transdermique |
WO1996037202A1 (fr) * | 1995-05-22 | 1996-11-28 | Alza Corporation | Forme galenique contenant de l'oxybutynine |
WO1998000126A1 (fr) * | 1996-06-28 | 1998-01-08 | Sepracor, Inc. | Utilisation de (s)-oxybutynine et de (s)-desethyloxybutynine pour traiter l'incontinence urinaire |
WO1999024106A1 (fr) * | 1997-11-06 | 1999-05-20 | Situs Corporation | Infuseur intravesical |
WO1999048494A1 (fr) * | 1998-03-26 | 1999-09-30 | Alza Corporation | Composition d'oxybutine a liberation continue et effet de xerostomie reduit |
-
2000
- 2000-06-09 WO PCT/US2000/040183 patent/WO2000076490A2/fr active Application Filing
- 2000-06-09 AU AU64036/00A patent/AU6403600A/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04273818A (ja) * | 1991-02-28 | 1992-09-30 | Kissei Pharmaceut Co Ltd | 経皮投与製剤 |
JPH05339151A (ja) * | 1992-05-30 | 1993-12-21 | Kodama Kk | 持効性塩酸オキシブチニン製剤 |
US5532278A (en) * | 1995-01-31 | 1996-07-02 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin |
WO1996033678A1 (fr) * | 1995-04-26 | 1996-10-31 | Theratech, Inc. | Utilisation de la triacetine comme stimulation de penetration transdermique |
WO1996037202A1 (fr) * | 1995-05-22 | 1996-11-28 | Alza Corporation | Forme galenique contenant de l'oxybutynine |
WO1998000126A1 (fr) * | 1996-06-28 | 1998-01-08 | Sepracor, Inc. | Utilisation de (s)-oxybutynine et de (s)-desethyloxybutynine pour traiter l'incontinence urinaire |
WO1999024106A1 (fr) * | 1997-11-06 | 1999-05-20 | Situs Corporation | Infuseur intravesical |
WO1999048494A1 (fr) * | 1998-03-26 | 1999-09-30 | Alza Corporation | Composition d'oxybutine a liberation continue et effet de xerostomie reduit |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 199404, Derwent World Patents Index; AN 1994-031722, XP002183937 * |
PATENT ABSTRACTS OF JAPAN vol. 0, no. 0 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000076490A2 (fr) | 2000-12-21 |
AU6403600A (en) | 2001-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2211400A1 (fr) | Traitement de l'incontinence urinaire par la (s)-oxybutynine et la (s)-desethyloxybutynine | |
CA2257121A1 (fr) | Methodes et compositions pour le traitement de l'incontinence urinaire utilisant (s)-oxybutynine | |
AU4856097A (en) | Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments | |
MY127946A (en) | Therapeutic formulation for administering tolterodine with controlled release | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
WO2000071108A3 (fr) | Procedes de traitement de l'asthme a l'aide de s-oxybutynine | |
CA2180535A1 (fr) | Procede de traitement du psoriasis par omeprazole ou autres composes apparentes | |
MY129130A (en) | (+)-norcisapride | |
HK1024631A1 (en) | Use of (+) mefloquine for the treatment of malaria | |
WO2000051582A3 (fr) | Procedes de traitement de l'apnee et de troubles de l'apnee a l'aide de r(+) ondansetron optiquement pur | |
WO2000076490A3 (fr) | Methodes de traitement de la frequence exageree des mictions ainsi que les mictions imperieuses a l'aide de oxybutynine-(s) optiquement pure et compositions a cet effet | |
WO2003002059A3 (fr) | Metabolites de tolterodine | |
AU4039799A (en) | Method for the racemization of optically active amines | |
AU4976599A (en) | Method for treatment of fibrosis related diseases by the administration of prostacyclin derivatives | |
WO2001000187A3 (fr) | Agents therapeutiques | |
WO1999033454A3 (fr) | Procyclidine-s aux fins du traitement de l'incontinence urinaire | |
WO1996021670A3 (fr) | Fusacandines antifongiques | |
WO2000010544A3 (fr) | Procede prevenant l'apparition de l'asthme | |
AU6470400A (en) | Nitroxy derivatives of (r) and (s)-carnitine | |
AU2668201A (en) | Method for the production of optically active cyanohydrins using r-oxynitrilase | |
WO1999033453A3 (fr) | R-procyclidine utilisee dans le traitement de l'incontinence urinaire | |
AU2819500A (en) | Process for the preparation of asymmetrical 1,4-dihydro-pyridine-dicarboxylic acid esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |